Patent ductus arteriosus in extremely preterm infants receiving phototherapy: does shielding the chest make a difference?: a randomized, controlled trial.

J. Travadi, Karen Simmer, J. Ramsay, Dorota Doherty, Ronald Hagan

    Research output: Contribution to journalArticlepeer-review

    14 Citations (Scopus)

    Abstract

    Background: Patent ductus arteriosus (PDA), a common complication in extremely preterm infants, is associated with increased mortality and morbidity. Phototherapy has been associated with PDA, and one randomized, control trial has shown that shielding of the chest may decrease the risk of PDA. Aim: To examine if chest shielding reduces the incidence and severity of PDA in extremely preterm infants. Study design: Randomized clinical trial of infants <29 wk gestation (stratified into two groups:
    Original languageEnglish
    Pages (from-to)1418-1423
    JournalActa Paediatrica
    Volume95
    Issue number11
    DOIs
    Publication statusPublished - 2006

    Fingerprint

    Dive into the research topics of 'Patent ductus arteriosus in extremely preterm infants receiving phototherapy: does shielding the chest make a difference?: a randomized, controlled trial.'. Together they form a unique fingerprint.

    Cite this